logo
Share SHARE
FONT-SIZE Plus   Neg

Abbott Xience Xpedition Drug Eluting Stent Gets Approval In Japan

Healthcare company Abbott Laboratories (ABT) said Wednesday that it has received approval for its next-generation Xience Xpedition everolimus eluting coronary stent system in Japan. The approval boosts Abbott's efforts to globally expand its drug-eluting stent systems.

The company said that Japan's Ministry of Health, Labor and Welfare approved the Xience Xpedition stent for the treatment of coronary artery disease or CAD, the most common form of heart disease, in Japan. Heart disease is one of the leading causes of death in Japan, accounting for nearly one-third of all deaths in the country.

Abbott noted that the Xience Xpedition's enhanced deliverability, combined with the broadest size matrix in the Japanese market that includes a unique 3.25 mm diameter for more accurate vessel sizing, will help physicians in Japan address a wide range of patients with CAD.

Masahisa Yamane, director, Cardiovascular Division of Saitama Sekishinkai Hospital in Saitama, Japan said, "The deliverability with Xience Xpedition is impressive, helping physicians navigate with ease through complex blockages inside the heart vessels. This approval offers physicians an important new treatment option to address a growing health concern in Japan; we look forward to the positive impact of this product in Japanese patients with coronary heart disease."

Xience Xpedition is currently available in the U.S, Europe, the Middle East and parts of Asia.

In Japan, five Abbott-sponsored trials involving more than 3,000 patients implanted with either Xience V or Xience Prime have been conducted. Several other studies, including investigator-initiated trials, have been conducted since the original launch in Japan of Xience V in 2010.

In Wednesday's regular trading session, ABT is trading at $35.07, up $0.33 or 0.94 percent on a volume of 906,625 shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Xiaomi Corp., nicknamed the "Apple of China" is planning to launch laptops, a report by Bloomberg said. The Chinese brand has been pausing a direct challenge to major smart phone brands in Asian markets in the recent years. It has planned to win over China, India and Brazil markets those together would account for one third of the worldwide sales. Value-priced fashion apparel and accessories retailer Cato Corp. (CATO) Thursday announced a four percent increase in comparable store sales for August. Sales were for the four week period was up five percent to $67 percent from $63.6 million last year. For the thirty weeks ended August 29, the... Simple, uncluttered, colorful and friendly. That's how Google describes its new logo. The new typeface is sans-serif and without any shadow or embossing, unlike its earlier logos. It has given blue, red, yellow and green to its letters. The "e" is slightly tilted and stylized. On its browser tabs, it has replaced the lower case blue colored "g" with an upper case "G" in four colors.
comments powered by Disqus
RELATED NEWS
Trade ABT now with 
Follow RTT